Physician profile
Eric Shang
NPI 1942462262
$5,777.98
in general payments reported to CMS, 2019-2025
23 companies · $3,086 in 2025
The $3,086 reported for 2025 was more than what 78% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,415 · 2020: $185 · 2021: $189 · 2022: $276 · 2023: $483 · 2024: $145 · 2025: $3,086.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,040 · Food and Beverage: $1,673.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,040.00 |
| Food and Beverage | $1,673.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $2,040.00 | 2025 | |
| Bard Peripheral Vascular, INC. | $663.44 | 2019 | |
| Abbott Laboratories | $607.80 | 2019-2024 | Emboshield Nav6, Perclose Prostyle |
| Medtronic, INC. | $429.16 | 2023-2025 | Endurant Iis, Corevalve Evolut R |
| Cook Medical LLC | $394.98 | 2019-2025 | Icast Covered Stent System, 6mmx22mmx120cm, Zenith Spiral-Z |
| Bolton Medical INC | $316.54 | 2022-2025 | Treo Abdominal Stent-Graft System |
| Medtronic Vascular, INC. | $311.66 | 2019 | |
| Endologix LLC | $234.28 | 2020-2021 | |
| W. L. Gore & Associates, INC. | $160.62 | 2019-2023 | Gore Tag Thoracic Branch Endoprosthesis |
| Boston Scientific Corporation | $148.22 | 2025 | Enroute Transcarotid Neuroprotection System |
| Silk Road Medical, INC. | $87.80 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| E.R. Squibb & Sons, L.L.C. | $61.57 | 2022 | |
| Novartis Pharmaceuticals Corporation | $56.47 | 2021-2022 | |
| Novo Nordisk INC | $56.35 | 2022 | |
| Baxter Healthcare | $51.43 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.25 | 2021-2022 | |
| Amgen INC. | $28.73 | 2020-2021 | |
| Argon Medical Devices, INC. | $25.49 | 2021 | |
| Amarin Pharma, INC. | $14.45 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.05 | 2022 | |
| Sanofi-Aventis U.S. LLC | $13.19 | 2022 | |
| Angiodynamics, INC. | $13.14 | 2020 | |
| Cardiovascular Systems INC. | $6.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Shang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.